http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013213219-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d1533b981887ddba694ad1c4f8afc141 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-787 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08G69-08 |
| filingDate | 2013-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27080b267cd3eeb5b2554230cf519888 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6e3839776b526f97fc981dff292b533 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0055f23c7f598c079974204c2679917c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7274d1e568cd40b417e1c19aca3f5af |
| publicationDate | 2013-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2013213219-A |
| titleOfInvention | Polyamides for treating human papillomavirus |
| abstract | The present invention relates to a polyamide composition and therapy for treating cells infected with human papillomavirus (HPV). Provided is a compound of the formula: Z- (X) n -γ q- (X) m -YA, or a pharmaceutically acceptable salt thereof, wherein m + 3 is at least 11; n = M-o; o is 0, 1 or 2; Z is QC (O)-; γ q is Formula IV and Formula VI, (S) -2,4-diaminobutyric acid in the specification Selected from the group consisting of formula γ1, formula γ2, formula γ3 and formula γ4 in the specification and enantiomers of formula IX and formula IX; Y is the formula III, formula I, formula II and formula X7 and C in the specification 1-6 independently selected from the group consisting of aliphatic amino acids and natural α-amino acids; A is Formula A1, Formula A2, Formula A3, Formula A4, Formula A5, Formula A6, Formula A7, Formula A8 in the specification. , Selected from the group consisting of Formula A9, Formula A10, Formula A11, and the like. ]. [Selection figure] None |
| priorityDate | 2006-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 345.